Clinical Trials Directory

Trials / Completed

CompletedNCT01897324

IVF/ICSI Protocols in Poor Responders With Growth Hormone

Which is the Best IVF/ICSI Protocol to be Used in Poor Responders Receiving Growth Hormone as an Adjuvant Treatment ? A Prospective Randomized Study

Status
Completed
Phase
Phase 4
Study type
Interventional
Enrollment
287 (actual)
Sponsor
Woman's Health University Hospital, Egypt · Academic / Other
Sex
Female
Age
20 Years – 45 Years
Healthy volunteers
Not accepted

Summary

in this study, we are trying to monitor the effect of the addition of growth hormone on the different down regulation protocols ( long, short, antagonist and microflare). The outcome will be primarily assessed by the clinical pregnancy rates.

Detailed description

Poor responders undergoing IVF/ICSI cycles have emerged as a major problem. the need to find a proper stimulation protocol is a must. in this study we are trying to detect the best stimulation protocol ,in addition to growth hormone ,that can give the highest pregnancy rates in these patients.

Conditions

Interventions

TypeNameDescription
DRUGGrowth hormone (Norditropin, Novo nordisk)

Timeline

Start date
2013-07-01
Primary completion
2015-01-01
Completion
2015-01-01
First posted
2013-07-11
Last updated
2015-10-20

Locations

1 site across 1 country: Egypt

Source: ClinicalTrials.gov record NCT01897324. Inclusion in this directory is not an endorsement.

IVF/ICSI Protocols in Poor Responders With Growth Hormone (NCT01897324) · Clinical Trials Directory